Hsiao Yu-Ping, Lu Chun-Te, Chang-Chien Ju, Chao Wan-Ru, Yang Jiann-Jou
Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan.
Department of Dermatology, Chung Shan Medical University Hospital, Taichung 402, Taiwan.
Materials (Basel). 2016 Jun 14;9(6):464. doi: 10.3390/ma9060464.
The Ion Torrent Personal Genome Machine (Ion PGM) is a semiconductor-based sequencing technology that is high quality, scalable, and economic. Its applications include genomic sequencing, drug resistance testing, microbial characterization, and targeted sequencing in cancer studies. However, little is known about the application of Ion PGM in cutaneous squamous cell carcinoma (cSCC). We therefore investigated the utility and validity of Ion PGM in cSCC and also gained a better understanding of the underlying molecular biology of cSCC. We detected novel gene mutations (KDR, FGFR2, and EGFR) in two cSCC patients. Moreover, we validated these mutations by pyrosequencing and Sanger sequencing. Our results indicated that the mutation screen using Ion PGM is consistent with traditional sequencing methods. Notably, these identified mutations were present at significantly higher rates in high-risk cSCC. Our results demonstrate a method to detect targetable genes in high-risk cSCC, and suggest that Ion PGM may enable therapeutic decision-making and future potential targets for personalized therapies in cSCC.
离子激流个人基因组测序仪(Ion PGM)是一种基于半导体的测序技术,具有高质量、可扩展性和经济性。其应用包括基因组测序、耐药性检测、微生物特征分析以及癌症研究中的靶向测序。然而,关于Ion PGM在皮肤鳞状细胞癌(cSCC)中的应用知之甚少。因此,我们研究了Ion PGM在cSCC中的实用性和有效性,并对cSCC潜在的分子生物学有了更好的理解。我们在两名cSCC患者中检测到了新的基因突变(KDR、FGFR2和EGFR)。此外,我们通过焦磷酸测序和桑格测序验证了这些突变。我们的结果表明,使用Ion PGM进行突变筛查与传统测序方法一致。值得注意的是,这些已鉴定的突变在高危cSCC中的发生率显著更高。我们的结果证明了一种在高危cSCC中检测可靶向基因的方法,并表明Ion PGM可能有助于cSCC的治疗决策制定以及个性化治疗的未来潜在靶点。